Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Thermo Fisher Scientific PCT Assay for Sepsis Available for Abbott Analyzers

January 30, 2012 By AxoGen, Inc.

WALTHAM,
Mass. – Thermo Fisher
Scientific, the world leader in serving science, today announced an agreement
with global healthcare provider Abbott Laboratories to make its Procalcitonin
(PCT) assay available with Abbotts immunochemistry analyzers.

The companys Thermo Scientific B.R.A.H.M.S Procalcitonin
(PCT) assay will be available on Abbotts ARCHITECT® “i” and “ci” series of
immunochemistry analyzers. Abbotts high-, medium-, and low-volume integrated
diagnostic testing solutions leverage software, reagents, and sample carrier to
enable labs to standardize lab operations on a single platform. In turn,
laboratories are able to optimize processes, minimize errors and reduce result
variability, an increasingly important consideration as clinicians rely more
heavily on laboratory diagnostics to guide their treatment decisions.

“Earlier diagnosis of sepsis and other healthcare associated
infections can significantly lower healthcare costs and, most important,
improve patient outcomes,” said Ken Berger, senior vice president of Thermo
Fisher Scientifics specialty diagnostics business, “Our agreement with Abbott
makes it possible for more hospitals and laboratories globally to adopt a
proven PCT testing regimen that benefits patients and the entire healthcare
industry.”

Thermo Fisher will manufacture the Abbott ARCHITECT B.R.A.H.M.S
PCT assay and has exclusive distribution rights in relevant European markets.

Severe sepsis strikes more than 750,000 Americans each year,
and between 28 to 50 percent of patients die within the first month of
diagnosis. Hospital costs to treat severe sepsis in the U.S. are
estimated at $16 billion dollars annually. Much of this cost is attributed to
misdiagnosis or delayed diagnosis, making faster, more accurate detection a
national, if not global, imperative.  Research published in Critical Care
Medicine showed that each hour of delay in therapy can decrease chances of
patient survival by 7.6 percent.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. Our
mission is to enable our customers to make the world healthier, cleaner and
safer. With revenues of nearly $11 billion, we have approximately 37,000
employees and serve customers within pharmaceutical and biotech companies,
hospitals and clinical diagnostic labs, universities, research institutions and
government agencies, as well as in environmental and process control
industries. We create value for our key stakeholders through two premier brands,
Thermo Scientific and Fisher Scientific, which offer a unique combination of
continuous technology development and the most convenient purchasing options.
Our products and services help accelerate the pace of scientific discovery, and
solve analytical challenges ranging from complex research to routine testing to
field applications. Visit www.thermofisher.com.

Posted by Sean Fenske, Editor-in-Chief, MDT

Related Articles Read More >

CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech